EE+ POEM Archive
For very-high-risk patients, evolocumab reduces myocardial infarction (NNT = 71) and revascularization (NNT = 42) over 4.6 years (VESALIUS)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "For Very-high-risk Patients, Evolocumab Reduces Myocardial Infarction (NNT = 71) and Revascularization (NNT = 42) Over 4.6 Years (VESALIUS)." EE+ POEM Archive, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377598/all/For_very_high_risk_patients__evolocumab_reduces_myocardial_infarction__NNT_=_71__and_revascularization__NNT_=_42__over_4_6_years__VESALIUS_.
For very-high-risk patients, evolocumab reduces myocardial infarction (NNT = 71) and revascularization (NNT = 42) over 4.6 years (VESALIUS). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377598/all/For_very_high_risk_patients__evolocumab_reduces_myocardial_infarction__NNT_=_71__and_revascularization__NNT_=_42__over_4_6_years__VESALIUS_. Accessed March 6, 2026.
For very-high-risk patients, evolocumab reduces myocardial infarction (NNT = 71) and revascularization (NNT = 42) over 4.6 years (VESALIUS). (2026). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377598/all/For_very_high_risk_patients__evolocumab_reduces_myocardial_infarction__NNT_=_71__and_revascularization__NNT_=_42__over_4_6_years__VESALIUS_
For Very-high-risk Patients, Evolocumab Reduces Myocardial Infarction (NNT = 71) and Revascularization (NNT = 42) Over 4.6 Years (VESALIUS) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2026. [cited 2026 March 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377598/all/For_very_high_risk_patients__evolocumab_reduces_myocardial_infarction__NNT_=_71__and_revascularization__NNT_=_42__over_4_6_years__VESALIUS_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - For very-high-risk patients, evolocumab reduces myocardial infarction (NNT = 71) and revascularization (NNT = 42) over 4.6 years (VESALIUS)
ID - 3377598
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/3377598/all/For_very_high_risk_patients__evolocumab_reduces_myocardial_infarction__NNT_=_71__and_revascularization__NNT_=_42__over_4_6_years__VESALIUS_
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
